Division of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Department of Pathology, Washington University in St. Louis School of Medicine, St. Louis, MO, United States.
Front Immunol. 2022 Sep 30;13:973211. doi: 10.3389/fimmu.2022.973211. eCollection 2022.
Cardiac immunology studies in murine models have identified a sizeable population of myocardial B-cells and have shown that its modulation represents a promising strategy to develop novel therapies for heart failure. However, scarce data on B-cells in the human heart leaves unclear whether findings in rodents are relevant to human biology.
We performed immunohistochemical stains to characterize the amount and distribution of B-cells in human hearts, analyzing both fresh and post-mortem tissue. To gain insight into the biology of human myocardial B-cells we analyzed publicly-available spatial transcriptomics and single-cell sequencing datasets of myocardial and peripheral blood mononuclear cells (PBMCs). We validated these findings on primary B-cells sorted from the heart and peripheral blood of left ventricular assistive device recipients. To identify biological pathways upregulated in myocardial B-cells across species, we compared differential gene expression in myocardial vs peripheral blood B-cells across the studied human datasets and published rodent datasets.
In healthy human heart samples, we found B-cells at a ratio of 1:8 compared to T-cells (2.41 ± 0.45 vs 19.36 ± 4.43, p-value <0.001). Myocardial B-cells were more abundant in the interstitium compared with the intravascular space (p-value=0.011), and also more abundant in the myocardium vs. epicardium (p-value=0.048). Single-cell gene expression analysis showed that the human myocardium harbored mostly naive B-cells with a gene expression profile distinct from that of PBMC B-cells. Cross-comparison of differentially-expressed genes in myocardial vs. PBMC B-cells across human and rodent datasets identified 703 genes with consistent differential gene expression across species (binomial p-value=2.9e-48). KEGG pathway analysis highlighted "B-cell receptor signaling pathway," "Antigen processing and presentation," and "Cytokine-cytokine receptor interaction" among the top pathways upregulated in cardiac B-cells (FDR <0.001) conserved between species.
Like the murine heart, the human heart harbors naive B-cells that are both intravascular and extravascular. Human myocardial B-cells are fewer and more evenly distributed between these two compartments than rodent myocardial B-cells. However, analysis of single-gene expression data indicates that the biological function of myocardial B-cells is conserved across species.
在鼠模型中的心脏免疫学研究中发现了相当数量的心肌 B 细胞,并表明其调节可能代表开发心力衰竭新疗法的有前途的策略。然而,关于人类心脏中 B 细胞的稀缺数据尚不清楚啮齿动物中的发现是否与人类生物学相关。
我们进行了免疫组织化学染色,以表征人类心脏中 B 细胞的数量和分布,分析了新鲜和死后组织。为了深入了解人类心肌 B 细胞的生物学特性,我们分析了公开的心肌和外周血单核细胞 (PBMC) 的空间转录组学和单细胞测序数据集。我们在从左心室辅助装置接受者的心脏和外周血中分离的原代 B 细胞上验证了这些发现。为了确定跨物种上调的心肌 B 细胞中的生物学途径,我们比较了研究中人类数据集和已发表的啮齿动物数据集中心肌与外周血 B 细胞之间的差异基因表达。
在健康的人类心脏样本中,我们发现 B 细胞与 T 细胞的比例为 1:8(2.41 ± 0.45 与 19.36 ± 4.43,p 值 <0.001)。与血管内空间相比,心肌 B 细胞在间质中更为丰富(p 值=0.011),与心外膜相比也更为丰富(p 值=0.048)。单细胞基因表达分析表明,人类心肌主要含有幼稚 B 细胞,其基因表达谱与 PBMC B 细胞不同。在人类和啮齿动物数据集中,比较心肌与 PBMC B 细胞之间差异表达基因的单细胞基因表达分析表明,有 703 个基因在物种间具有一致的差异基因表达(二项式 p 值=2.9e-48)。KEGG 途径分析突出了“B 细胞受体信号通路”、“抗原加工和呈递”和“细胞因子-细胞因子受体相互作用”等在心脏 B 细胞中上调的前几个途径(FDR <0.001)在物种间保守。
与鼠类心脏一样,人类心脏也含有既存在于血管内又存在于血管外的幼稚 B 细胞。与啮齿动物心肌 B 细胞相比,人类心肌 B 细胞数量较少,在这两个隔室之间分布更为均匀。然而,单细胞基因表达数据分析表明,心肌 B 细胞的生物学功能在物种间是保守的。